CEO sold ~$287K of UTHR shares in the open market

Past results only. Not a forecast.

Record ID

0001106578-26-000119

Filed / recorded

Aug 14, 2026, 1:09 AM UTC

Added to OQRO

Oct 6, 2026, 9:34 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

UNITED THERAPEUTICS Corp

Issuer CIK

1082554

Ticker

UTHR

Reporting person

Martine A Rothblatt

Relationship

Director, Officer

Officer title

Chairperson & CEO

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Aug 12, 2026

Transaction code

S

Shares / units

558

Price per share

$514.18

Acquired / disposed

Disposed (D)

Shares owned after

329,725

Ownership form

Indirect — by Trust

Amendment

No

1. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
2. This transaction was executed in multiple trades at prices ranging from $513.55 to $514.525. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.